PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (NASDAQ:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has received
For more information, please visit
http://www.businesswire.com/news/home/20080722006352/en